Polymicrobial Wound Triple Cover — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — IV Flucloxacillin (MSSA) plus IV Ceftriaxone (E
Polymicrobial wound infections require combination therapy targeting each organism class: (1) Flucloxacillin for MSSA (narrow-spectrum, targeted), (2) Ceftriaxone for E. coli (3rd-generation cephalosporin with good Gram-negative coverage), (3) Metronidazole for B. fragilis (best anaerobic coverage). Alternatively, Piperacillin/Tazobactam alone could cover all three as a single agent — but targeted therapy is preferred when organisms and susceptibilities are known. The regimen can be rationalised to narrow-spectrum agents once full susceptibility data is available.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/infections